Avantor (AVTR)
(Delayed Data from NYSE)
$22.37 USD
+1.20 (5.67%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $22.36 -0.01 (-0.04%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth C Momentum B VGM
Brokerage Reports
0 items in cart
Avantor, Inc. [AVTR]
Reports for Purchase
Showing records 61 - 80 ( 134 total )
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
2022 Life Sciences and MedTech Conference: Day 1 Takeaways
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
COVID-19 Diagnostics: NT & LT Estimates Appear Conservative
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Preannouncement Dud, but Lonza Day Suggests Dandy Outlook
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
''Thermoesque'' Business Model Driving Multiple Expansion; Raise PT to $51
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Company: Avantor, Inc.
Industry: Medical Services
The "New" Avantor Beginning to Shine - Raising PT to $45
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Avantor, Inc.
Industry: Medical Services
Life Science Tools - Vaccine, Bioproduction, mRNA, Cell & Gene Therapy and M&A: 2H21 Outlook
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department